These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1636665)

  • 1. Synthetic surfactant replacement therapy decreases estimated pulmonary artery pressure in respiratory distress syndrome.
    Kääpä P; Kero P; Saraste M
    Am J Dis Child; 1992 Aug; 146(8):961-4. PubMed ID: 1636665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hemodynamics after synthetic surfactant replacement in neonatal respiratory distress syndrome.
    Kääpä P; Seppänen M; Kero P; Saraste M
    J Pediatr; 1993 Jul; 123(1):115-9. PubMed ID: 8320604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doppler-derived systolic pulmonary artery pressure in acute neonatal respiratory distress syndrome.
    Seppänen MP; Kääpä PO; Kero PO; Saraste M
    Pediatrics; 1994 May; 93(5):769-73. PubMed ID: 8165076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of synthetic surfactant replacement on pulmonary blood flow in neonatal respiratory distress syndrome.
    Seppänen M; Kääpä P; Kero P
    Am J Perinatol; 1994 Nov; 11(6):382-5. PubMed ID: 7857426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot observational study on haemodynamic changes after surfactant administration in preterm newborns with respiratory distress syndrome.
    Vitali F; Galletti S; Aceti A; Aquilano G; Fabi M; Balducci A; Faldella G
    Ital J Pediatr; 2014 Mar; 40(1):26. PubMed ID: 24594243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary haemodynamics after surfactant replacement in severe neonatal respiratory distress syndrome.
    Bloom MC; Roques-Gineste M; Fries F; Lelong-Tissier MC
    Arch Dis Child Fetal Neonatal Ed; 1995 Sep; 73(2):F95-8. PubMed ID: 7583614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral blood flow velocity changes after rapid administration of surfactant.
    Cowan F; Whitelaw A; Wertheim D; Silverman M
    Arch Dis Child; 1991 Oct; 66(10 Spec No):1105-9. PubMed ID: 1750756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant.
    Shimada S; Kasai T; Konishi M; Fujiwara T
    J Pediatr; 1994 Aug; 125(2):270-7. PubMed ID: 8040777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral blood flow velocity changes after bovine natural surfactant instillation.
    Nuntnarumit P; Bada HS; Yang W; Korones SB
    J Perinatol; 2000 Jun; 20(4):240-3. PubMed ID: 10879337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant.
    Abbasi S; Bhutani VK; Gerdes JS
    J Pediatr; 1993 Mar; 122(3):446-52. PubMed ID: 8441104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic prediction of complications in neonatal respiratory distress syndrome.
    Seppänen MP; Kääpä PO; Kero PO
    J Pediatr; 1995 Nov; 127(5):780-5. PubMed ID: 7472836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in hemodynamics after rescue surfactant administration.
    Katheria AC; Leone TA
    J Perinatol; 2013 Jul; 33(7):525-8. PubMed ID: 23328925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant replacement therapy for preterm and term neonates with respiratory distress.
    Polin RA; Carlo WA; ;
    Pediatrics; 2014 Jan; 133(1):156-63. PubMed ID: 24379227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intracardiac hemodynamic changes in the newborns with respiratory distress syndrome].
    Perepelitsa SA; Korotkaia MV; Pavlenko OV; Golubev AM
    Anesteziol Reanimatol; 2009; (1):37-40. PubMed ID: 19348326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effect of three doses of a synthetic surfactant on the alveolar-arterial oxygen gradient in infants weighing > or = 1250 grams with respiratory distress syndrome. American Exosurf Neonatal Study Group II.
    Berry DD; Pramanik AK; Philips JB; Buchter DS; Kanarek KS; Easa D; Kopelman AE; Edwards K; Long W
    J Pediatr; 1994 Feb; 124(2):294-301. PubMed ID: 8301442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant.
    Bhutani VK; Abbasi S; Long WA; Gerdes JS
    J Pediatr; 1992 Feb; 120(2 Pt 2):S18-24. PubMed ID: 1735846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in pulmonary artery pressure in infants with respiratory distress syndrome following treatment with Exosurf.
    Hamdan AH; Shaw NJ
    Arch Dis Child Fetal Neonatal Ed; 1995 May; 72(3):F176-9. PubMed ID: 7796233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in pulmonary mechanics after the administration of surfactant to infants with respiratory distress syndrome.
    Davis JM; Veness-Meehan K; Notter RH; Bhutani VK; Kendig JW; Shapiro DL
    N Engl J Med; 1988 Aug; 319(8):476-9. PubMed ID: 3405254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.